The UK pharma industry is to set up a road map setting out recommendations on how to protect and grow the respected UK ‘Pharmaceutical Brand’ with a specific focus on Technology and Innovation (T&I).
Historically, the UK has excelled at early innovation in medicines platform research and development, but has lost out to other countries for the final manufacture of these high value products. The Medicine Manufacturing Industry Partnership (MMIP) now defines via a road map building on strategic technology investments how to prepare the UK for the latest…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
